{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:16:55Z","timestamp":1761743815666},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T00:00:00Z","timestamp":1379030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s12020-013-0047-3","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T18:37:42Z","timestamp":1379011062000},"page":"241-248","source":"Crossref","is-referenced-by-count":18,"title":["Glycemic variability in normal glucose regulation subjects with elevated 1-h postload plasma glucose levels"],"prefix":"10.1007","volume":"46","author":[{"given":"Jian-bin","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,13]]},"reference":[{"key":"47_CR1","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc11-S062","volume":"34","author":"American Diabetes Association","year":"2011","unstructured":"American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 34, S62\u2013S69 (2011)","journal-title":"Diabetes Care"},{"key":"47_CR2","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","volume":"31","author":"MA Abdul-Ghani","year":"2008","unstructured":"M.A. Abdul-Ghani, T. Abdul-Ghani, N. Ali, R.A. Defronzo, One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31, 1650\u20131655 (2008)","journal-title":"Diabetes Care"},{"key":"47_CR3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2009.04.006","volume":"207","author":"E Succurro","year":"2009","unstructured":"E. Succurro, M.A. Marini, F. Arturi, A. Grembiale, M. Lugar\u00e0, F. Andreozzi, A. Sciacqua, R. Lauro, M.L. Hribal, F. Perticone, G. Sesti, Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207, 245\u2013249 (2009)","journal-title":"Atherosclerosis"},{"key":"47_CR4","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2215\/CJN.03240410","volume":"5","author":"E Succurro","year":"2010","unstructured":"E. Succurro, F. Arturi, M. Lugar\u00e0, A. Grembiale, T.V. Fiorentino, V. Caruso, F. Andreozzi, A. Sciacqua, M.L. Hribal, F. Perticone, G. Sesti, One-hour postload plasma glucose levels are associated with kidney dysfunction. Clin. J. Am. Soc. Nephrol. 5, 1922\u20131927 (2010)","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"47_CR5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/dmrr.938","volume":"25","author":"F Zaccardi","year":"2009","unstructured":"F. Zaccardi, D. Pitocco, G. Ghirlanda, Glycemic risk factors of diabetic vascular complications: the role of glycemic variability. Diabetes Metab. Res. Rev. 25, 199\u2013207 (2009)","journal-title":"Diabetes Metab. Res. Rev."},{"key":"47_CR6","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.295.14.1707","volume":"295","author":"M Brownlee","year":"2006","unstructured":"M. Brownlee, I.B. Hirsch, Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 295, 1707\u20131708 (2006)","journal-title":"JAMA"},{"key":"47_CR7","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1210\/jc.2010-2756","volume":"96","author":"DC Klonoff","year":"2011","unstructured":"D.C. Klonoff, B. Buckingham, J.S. Christiansen, V.M. Montori, W.V. Tamborlane, R.A. Vigersky, H. Wolpert, Endocrine society, continuous glucose monitoring: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96, 2968\u20132979 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"47_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12020-012-9765-1","volume":"43","author":"N Mauras","year":"2013","unstructured":"N. Mauras, L. Fox, K. Englert, R.W. Beck, Continuous glucose monitoring in type 1 diabetes. Endocrine 43, 41\u201350 (2013)","journal-title":"Endocrine"},{"key":"47_CR9","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1089\/dia.2010.0247","volume":"13","author":"NR Hill","year":"2011","unstructured":"N.R. Hill, N.S. Oliver, P. Choudhary, J.C. Levy, P. Hindmarsh, D.R. Matthews, Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol. Ther. 13, 921\u2013928 (2011)","journal-title":"Diabetes Technol. Ther."},{"key":"47_CR10","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2337\/dc05-1711","volume":"29","author":"MA Abdul-Ghani","year":"2006","unstructured":"M.A. Abdul-Ghani, K. Williams, R. DeFronzo, M. Stern, Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 29, 1613\u20131618 (2006)","journal-title":"Diabetes Care"},{"key":"47_CR11","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","volume":"29","author":"MA Abdul-Ghani","year":"2006","unstructured":"M.A. Abdul-Ghani, D. Tripathy, R.A. DeFronzo, Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29, 1130\u20131139 (2006)","journal-title":"Diabetes Care"},{"key":"47_CR12","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/db07-0954","volume":"57","author":"A Festa","year":"2008","unstructured":"A. Festa, K. Williams, A.J. Hanley, S.M. Haffner, Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test. Diabetes 57, 1638\u20131644 (2008)","journal-title":"Diabetes"},{"key":"47_CR13","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc06-1331","volume":"30","author":"MA Abdul-Ghani","year":"2007","unstructured":"M.A. Abdul-Ghani, K. Williams, R.A. DeFronzo, M. Stern, What is the best predictor of future type 2 diabetes? Diabetes Care 30, 1544\u20131548 (2007)","journal-title":"Diabetes Care"},{"key":"47_CR14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","volume":"23","author":"M Stumvoll","year":"2000","unstructured":"M. Stumvoll, A. Mitrakou, W. Pimenta, T. Jenssen, H. Yki-J\u00e4rvinen, T. Van Haeften, W. Renn, J. Gerich, Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23, 295\u2013301 (2000)","journal-title":"Diabetes Care"},{"key":"47_CR15","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.2337\/dc11-2476","volume":"35","author":"JY Kim","year":"2012","unstructured":"J.Y. Kim, D.K. Coletta, L.J. Mandarino, G.Q. Shaibi, Glucose response curve and type 2 diabetes risk in Latino adolescents. Diabetes Care 35, 1925\u20131930 (2012)","journal-title":"Diabetes Care"},{"key":"47_CR16","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"M. Matsuda, R.A. DeFronzo, Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22, 1462\u20131470 (1999)","journal-title":"Diabetes Care"},{"key":"47_CR17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1507\/endocrj.EJ11-0157","volume":"59","author":"R Oka","year":"2012","unstructured":"R. Oka, K. Yagi, M. Sakurai, K. Nakamura, T. Moriuchi, S. Miyamoto, A. Nohara, M.A. Kawashiri, Y. Takeda, M. Yamagishi, Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. Endocr. J. 59, 55\u201364 (2012)","journal-title":"Endocr. J."},{"key":"47_CR18","first-page":"CR552","volume":"14","author":"J Zhou","year":"2008","unstructured":"J. Zhou, W. Jia, Y. Bao, X. Ma, W. Lu, H. Li, C. Hu, K. Xiang, Glycemic variability and its responses to intensive insulin treatment in newly diagnosed type 2 diabetes. Med. Sci. Monit. 14, CR552\u2013CR558 (2008)","journal-title":"Med. Sci. Monit."},{"key":"47_CR19","first-page":"CR9","volume":"17","author":"J Zhou","year":"2011","unstructured":"J. Zhou, H. Li, X. Ran, W. Yang, Q. Li, Y. Peng, Y. Li, X. Gao, X. Luan, W. Wang, W. Jia, Establishment of normal reference ranges for glycemic variability in Chinese subjects using continuous glucose monitoring. Med. Sci. Monit. 17, CR9\u2013CR13 (2011)","journal-title":"Med. Sci. Monit."},{"key":"47_CR20","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"L. Monnier, E. Mas, C. Ginet, F. Michel, L. Villon, J.P. Cristol, C. Colette, Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295, 1681\u20131687 (2006)","journal-title":"JAMA"},{"key":"47_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","volume":"32","author":"KM Utzschneider","year":"2009","unstructured":"K.M. Utzschneider, R.L. Prigeon, M.V. Faulenbach, J. Tong, D.B. Carr, E.J. Boyko, D.L. Leonetti, M.J. McNeely, W.Y. Fujimoto, S.E. Kahn, Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 32, 335\u2013341 (2009)","journal-title":"Diabetes Care"},{"key":"47_CR22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/oby.2008.307","volume":"16","author":"R Retnakaran","year":"2008","unstructured":"R. Retnakaran, S. Shen, A.J. Hanley, V. Vuksan, J.K. Hamilton, B. Zinman, Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity (Silver Spring) 16, 1901\u20131907 (2008)","journal-title":"Obesity (Silver Spring)"},{"key":"47_CR23","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1177\/193229680800200618","volume":"2","author":"L Monnier","year":"2008","unstructured":"L. Monnier, C. Colette, D.R. Owens, Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J. Diabetes Sci. Technol. 2, 1094\u20131100 (2008)","journal-title":"J. Diabetes Sci. Technol."},{"key":"47_CR24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/dia.2009.0015","volume":"11","author":"D Rodbard","year":"2009","unstructured":"D. Rodbard, New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol. Ther. 11, 551\u2013565 (2009)","journal-title":"Diabetes Technol. Ther."},{"key":"47_CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1055\/s-2008-1062723","volume":"40","author":"F Moreau","year":"2008","unstructured":"F. Moreau, M.A. Weiller, V. Rosner, L. Weiss, M. Hasselmann, M. Pinget, R. Kessler, L. Kessler, Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance. Horm. Metab. Res. 40, 502\u2013506 (2008)","journal-title":"Horm. Metab. Res."},{"key":"47_CR26","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/dia.2012.0333","volume":"15","author":"SV Madhu","year":"2013","unstructured":"S.V. Madhu, S.K. Muduli, R. Avasthi, Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients. Diabetes Technol. Ther. 15, 461\u2013465 (2013)","journal-title":"Diabetes Technol. Ther."},{"key":"47_CR27","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00125-010-1741-9","volume":"53","author":"R Borg","year":"2010","unstructured":"R. Borg, J.C. Kuenen, B. Carstensen, H. Zheng, D.M. Nathan, R.J. Heine, J. Nerup, K. Borch-Johnsen, D.R. Witte, ADAG Study Group, Real-life glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1C-derived average glucose (ADAG) study. Diabetologia 53, 1608\u20131611 (2010)","journal-title":"Diabetologia"},{"key":"47_CR28","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2265.2011.04205.x","volume":"76","author":"C Wang","year":"2012","unstructured":"C. Wang, L. Lv, Y. Yang, D. Chen, G. Liu, L. Chen, Y. Song, L. He, X. Li, H. Tian, W. Jia, X. Ran, Glucose fluctuations in subjects with normal glucose tolerance, impaired glucose regulation and newly diagnosed type 2 diabetes mellitus. Clin. Endocrinol. (Oxf.) 76, 810\u2013815 (2012)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"47_CR29","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.numecd.2011.02.006","volume":"21","author":"A Lapolla","year":"2011","unstructured":"A. Lapolla, A. Mosca, D. Fedele, The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go. Nutr. Metab. Cardiovasc. Dis. 21, 467\u2013475 (2011)","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"47_CR30","doi-asserted-by":"crossref","first-page":"e44470","DOI":"10.1371\/journal.pone.0044470","volume":"7","author":"A Sciacqua","year":"2012","unstructured":"A. Sciacqua, R. Maio, S. Miceli, A. Pascale, G. Carullo, N. Grillo, F. Arturi, G. Sesti, F. Perticone, Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS One 7, e44470 (2012)","journal-title":"PLoS One"},{"key":"47_CR31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.2337\/dc11-0155","volume":"34","author":"A Sciacqua","year":"2011","unstructured":"A. Sciacqua, S. Miceli, G. Carullo, L. Greco, E. Succurro, F. Arturi, G. Sesti, F. Perticone, One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34, 1406\u20131411 (2011)","journal-title":"Diabetes Care"},{"key":"47_CR32","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2337\/dc11-0879","volume":"34","author":"A Sciacqua","year":"2011","unstructured":"A. Sciacqua, S. Miceli, L. Greco, F. Arturi, P. Naccarato, D. Mazzaferro, E.J. Tassone, L. Turano, F. Martino, G. Sesti, F. Perticone, One-hour postload plasma glucose levels and diastolic function in hypertensive patients. Diabetes Care 34, 2291\u20132296 (2011)","journal-title":"Diabetes Care"},{"key":"47_CR33","first-page":"359","volume":"61","author":"N Taheri","year":"2010","unstructured":"N. Taheri, B. Iraj, M. Amini, P. Amini, A. Aminorroaya, Cardiovascular risk factors in relatives of type 2 diabetics with normal glucose tolerance test and elevated one-hour plasma glucose. Endokrynol. Pol. 61, 359\u2013363 (2010)","journal-title":"Endokrynol. Pol."},{"key":"47_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-12-1","volume":"12","author":"K Torimoto","year":"2013","unstructured":"K. Torimoto, Y. Okada, H. Mori, Y. Tanaka, Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus. Cardiovasc. Diabetol. 12, 1 (2013)","journal-title":"Cardiovasc. Diabetol."},{"key":"47_CR35","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"M. Brownlee, Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813\u2013820 (2001)","journal-title":"Nature"},{"key":"47_CR36","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"M. Brownlee, The pathophysiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615\u20131625 (2005)","journal-title":"Diabetes"},{"key":"47_CR37","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2337\/dc11-2181","volume":"35","author":"MA Marini","year":"2012","unstructured":"M.A. Marini, E. Succurro, S. Frontoni, S. Mastroianni, F. Arturi, A. Sciacqua, R. Lauro, M.L. Hribal, F. Perticone, G. Sesti, Insulin sensitivity, \u03b2-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels. Diabetes Care 35, 868\u2013872 (2012)","journal-title":"Diabetes Care"},{"key":"47_CR38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12020-012-9830-9","volume":"43","author":"M Bergman","year":"2013","unstructured":"M. Bergman, Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 43, 504\u2013513 (2013)","journal-title":"Endocrine"},{"key":"47_CR39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s001250100580","volume":"44","author":"RE Pratley","year":"2001","unstructured":"R.E. Pratley, C. Weyer, The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus. Diabetologia 44, 929\u2013945 (2001)","journal-title":"Diabetologia"},{"key":"47_CR40","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.diabres.2003.11.024","volume":"66","author":"M Fukushima","year":"2004","unstructured":"M. Fukushima, H. Suzuki, Y. Seino, Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res. Clin. Pract. 66, S37\u2013S43 (2004)","journal-title":"Diabetes Res. Clin. Pract."},{"key":"47_CR41","doi-asserted-by":"crossref","first-page":"M2","DOI":"10.1007\/s00125-002-0930-6","volume":"46","author":"S Prato Del","year":"2003","unstructured":"S. Del Prato, Loss of early insulin secretion leads to postprandial hyperglycaemia. Diabetologia 46, M2\u2013M8 (2003)","journal-title":"Diabetologia"},{"key":"47_CR42","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.2337\/diabetes.51.2007.S212","volume":"51","author":"RN Bergman","year":"2002","unstructured":"R.N. Bergman, M. Ader, K. Huecking, G. Van Citters, Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51, S212\u2013S220 (2002)","journal-title":"Diabetes"},{"key":"47_CR43","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2337\/dc08-1956","volume":"32","author":"KD Kohnert","year":"2009","unstructured":"K.D. Kohnert, P. Augstein, E. Zander, P. Heinke, K. Peterson, E.J. Freyse, R. Hovorka, E. Salzsieder, Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. Diabetes Care 32, 1058\u20131062 (2009)","journal-title":"Diabetes Care"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-0047-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-013-0047-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-0047-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:56:43Z","timestamp":1559440603000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-013-0047-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,13]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["47"],"URL":"https:\/\/doi.org\/10.1007\/s12020-013-0047-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,13]]}}}